BSGM (BioSig Technologies) Aset Bersih Perusahaan

The BSGM price chart illustrating trading dynamics shows indicators at the level of -0.00. Demand for signal filtering remains stable, although clinic procurement is constrained by capital budgets during the crisis. Biosig Technologies is implementing high-precision data processing in cardiology, establishing the PURE EP system as a diagnostic standard. Current growth is driven by the delivery of digital solutions while the market awaits the execution of new commercial agreements.

The scaling of PUREEP systems for cardiac surgery automation correlates directly with the dynamics of equity on the balance sheet. This indicator captures the difference between total assets and liabilities, allowing investors to assess the real value of Biosig Technologies (BSGM) net resources and the business's level of protection against inflationary risks through daily monitoring of equity accumulation.